
Pei-Ling Chen MD
Dermatopathology, Anatomic Pathology, Clinical Pathology
Physician
Join to View Full Profile
660 S Euclid AveSaint Louis, MO 63110
Phone+1 314-747-3000
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pei-Ling Chen, MD is a board certified pathologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Florida.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2010 - 2014
- The Warren Alpert Medical School of Brown UniversityClass of 2003
- University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology
Certifications & Licensure
- FL State Medical License 2017 - 2027
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 1 citationsEnabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies.Thomas Kuilman, Deborah S Schrikkema, Jules Gadiot, Raquel Gomez-Eerland, Laura Bies
Nature Communications. 2025-01-14 - Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma.Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany, Jonathan S Zager, Ricardo J Gonzalez
Clinical Cancer Research. 2024-12-02 - 1 citationsAchieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA).Yaohui G Xu, Young Lim, Jeremy S Bordeaux, Sumaira Z Aasi, Murad Alam
Journal of the National Comprehensive Cancer Network. 2024-11-01
Press Mentions
- Genomic Alterations Identified in Cutaneous T-cell Lymphoma Could Provide Path to New TherapiesMarch 1st, 2022
- Key Genomic Alterations and Potential Therapeutic Vulnerabilities Identified in Transformed Cutaneous T-cell LymphomaMarch 1st, 2022